IL-15 Increases the Frequency of Effector Memory CD8+ T Cells in Rhesus Monkeys Immunized with HIV Vaccine
Overview
Affiliations
Several studies have suggested that interleukin (IL)-15 is a promising adjuvant that promotes cellular immunity when administered with human immunodeficiency virus (HIV) vaccine. Here we evaluated the effect of IL-15 plasmid on HIV-specific immune responses, especially cellular immunity, in eight rhesus monkeys. These monkeys were immunized three times with HIV DNA vaccine with or without IL-15 plasmid and boosted with recombinant Tiantan strain vaccinia virus-based HIV vaccine (rTV) 22 weeks after the first immunization. Although we did not detect any significant differences in the HIV-specific CD8(+) T-cell response between monkeys with IL-15 coimmunization and monkeys with HIV vaccine alone, our results showed that the frequency of effector CD8(+) memory T cells in the peripheral blood was significantly higher in monkeys with IL-15 coimmunization than those with HIV vaccine alone at almost all of the time points examined. Furthermore, the titers of anti-HIV antibodies were higher in Group T than those in Group C after rTV boosting. These findings in rhesus monkeys suggest that IL-15 may be useful as a cytokine adjuvant for HIV vaccine.
Pena-Asensio J, Calvo-Sanchez H, Miquel J, Sanz-de-Villalobos E, Gonzalez-Praetorius A, Torralba M iScience. 2023; 27(1):108666.
PMID: 38155778 PMC: 10753074. DOI: 10.1016/j.isci.2023.108666.
Development of Stable Chimeric IL-15 for Trans-Presentation by the Antigen Presenting Cells.
Patidar M, Yadav N, Dalai S Front Immunol. 2021; 12:646159.
PMID: 33953717 PMC: 8092395. DOI: 10.3389/fimmu.2021.646159.
Dying to protect: cell death and the control of T-cell homeostasis.
Li K, Shanmuganad S, Carroll K, Katz J, Jordan M, Hildeman D Immunol Rev. 2017; 277(1):21-43.
PMID: 28462527 PMC: 5416827. DOI: 10.1111/imr.12538.
Anokhin V, Bakhteeva L, Khasanova G, Khaiboullina S, Martynova E, Tillett R Biomed Res Int. 2017; 2016:2742648.
PMID: 28050553 PMC: 5165134. DOI: 10.1155/2016/2742648.
Enhancing poxvirus vectors vaccine immunogenicity.
Garcia-Arriaza J, Esteban M Hum Vaccin Immunother. 2014; 10(8):2235-44.
PMID: 25424927 PMC: 4896794. DOI: 10.4161/hv.28974.